Fennec Pharmaceuticals (FENC) Interest Coverage Ratio Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 843.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 843.12% |
| Sep 30, 2025 | 93.64% |
| Jun 30, 2025 | 4.71% |
| Mar 31, 2025 | -110.27% |
| Dec 31, 2024 | 51.34% |
| Sep 30, 2024 | -327.17% |
| Jun 30, 2024 | 14.66% |
| Mar 31, 2024 | 301.26% |
| Dec 31, 2023 | 75.90% |
| Sep 30, 2023 | 98.21% |
| Jun 30, 2023 | 93.56% |
| Mar 31, 2023 | 89.20% |
| Dec 31, 2022 | 87.85% |
| Sep 30, 2022 | 12.51% |
| Jun 30, 2022 | 79.82% |
| Mar 31, 2022 | 95.03% |
| Jun 30, 2015 | 76.39% |